Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Check Out 3 Industrials Stocks With Over 4% Dividend Yields From Wall Street’s Most Accurate Analysts

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
byLisa Levin
July 27, 2023
2 minute read
Total
0
Shares
0
0
0
0
0
0

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy. Here’s a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga’s Analyst Stock Ratings.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the industrials sector.

Steelcase Inc. (NYSE:SCS)

  • Dividend Yield: 4.83%
  • Benchmark analyst Reuben Garner downgraded the stock from Buy to Hold on Nov. 30, 2022. This analyst has an accuracy rate of 81%.
  • Sidoti & Co. analyst Gregory burns downgraded the stock from Buy to Neutral on Sept. 15, 2022. This analyst has an accuracy rate of 72%.
  • Recent News: Steelcase reported better-than-expected first-quarter financial results and issued seconc-quarter 2024 adjusted EPS guidance.

ACCO Brands Corporation (NYSE:ACCO)

  • Dividend Yield: 5.22%
  • Barrington Research analyst Kevin Steinke reiterated an Outperform rating with a price target of $8 on June 2, 2023. This analyst has an accuracy rate of 66%.
  • BWS Financial analyst Hamed Khorsand downgraded the stock from Buy to Neutral and lowered the price target from $9 to $6 on Feb. 14, 2023. This analyst has an accuracy rate of 67%.
  • Recent News: ACCO Brands reported better-than-expected first-quarter results.

Star Bulk Carriers Corp. (NASDAQ:SBLK)

  • Dividend Yield: 8.05%
  • Jefferies analyst Omar Nokta maintained a Buy rating and cut the price target from $24 to $22 on June 6, 2023. This analyst has an accuracy rate of 67%.
  • Stifel analyst Benjamin Nolan maintained a Buy rating and raised the price target from $27 to $30 on April 25, 2023. This analyst has an accuracy rate of 72%.
  • Recent News: Star Bulk Carriers posted better-than-expected earnings for its first quarter.

 

Read More: Investor Sentiment Declines After Fed Raises Interest Rates By 0.25%

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Corcept Therapeutics Provides Financial Update And Announces $200M Stock Repurchase Program; Sees Q4 Revenue $135.4M Vs $127.85M Est.; FY23 Revenue $482.4M Vs $474.82M Est.; FY24 Revenue $600M–$630M Vs $513.85M Est.

By Benzinga Newsdesk
January 8, 9:28 AM
Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology disorders by modulating

CORT

Read More

Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows

By Jelena Martinovic
April 3, 11:12 AM
Older patients comprise a growing subset of medical cannabis patients, according to a new study. Titled Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada, the new scientific publication presented the consumption trends observed in patients and the self-reported impacts of medical cannabis in alleviating the patients' primary symptoms. Tilray Medical, a division of Tilray Brands, Inc. is behind the study which is derived from the Canadian Cannabis Patient Survey (CCPS) 2021, which included 2,697 patients. The researchers focused primarily on older patients with a mean age of 54.3. Patients with chronic pain (27.8%), arthritis (14.9%) and anxiety (9%) were the most numerous among those seeking cannabis to treat their primary illnesses. Pain was the most common primary symptom for which patients use medical cannabis, followed by anxiety and insomnia/sleep disorder.

TLRY